Compumedics Other Income/Expense
The Other Income/Expense (Net) of Compumedics (CMP.AX) as of Oct 8, 2026 is -125,000.00 AUD. In the previous year, Other Income/Expense (Net) was -1.31 M AUD — a change of -90.44% (higher).
Get this data via API
Financial Data API
Other Income/Expense
-125,000.00AUD
YoY
-90.44%
Last updated:
The Compumedics Other Income/Expense history
3 Years
10 Years
25 Years
Max
| YEAR | Other Income/Expense | YoY |
|---|---|---|
| -125,000.00AUD | -90.44% | |
| -1.31 MAUD | -201.16% | |
| 1.29 MAUD | -140.57% | |
| -3.19 MAUD | -304.04% | |
| 1.56 MAUD | +312.96% | |
| 378,000.00AUD | -105.60% | |
| -6.75 MAUD | -2,090.54% | |
| 338,953.00AUD | -45.75% | |
| 624,751.00AUD | -58.98% | |
| 1.52 MAUD | -16.27% | |
| 1.82 MAUD | +55.34% | |
| 1.17 MAUD | -17.71% | |
| 1.42 MAUD | — |
Compumedics Stock analysis
Frequently Asked Questions about Compumedics stock
Other Income/Expense (Net) of Compumedics is -125,000.00 AUD in 2026.
Other Income/Expense (Net) of Compumedics changed from -1.31 M AUD to -125,000.00 AUD, representing a -90.44% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of Other Income/Expense (Net) Compumedics since 2006 – with annual values, charts, and detailed analysis.
Other income and expense includes non-operating items such as gains/losses on investments, foreign exchange, and other non-core activities.
Other Income/Expense (Net)'s AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Other Income/Expense (Net)'s Compumedics historically and in real time.
Income Statement — Compumedics
All Key Metrics — Compumedics
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth